Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Glioblastoma”

511 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 511 results

Testing effectiveness (Phase 2)Study completedNCT00687765
What this trial is testing

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma
Sanofi 126
Testing effectiveness (Phase 2)Ended earlyNCT00574964
What this trial is testing

Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme

Who this might be right for
Primary Glioblastoma Multiforme
University of Iowa 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01985087
What this trial is testing

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Who this might be right for
Glioblastoma
University of Louisville 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195139
What this trial is testing

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Who this might be right for
Glioblastoma Multiforme
University of Sydney 103
Early research (Phase 1)Active Not RecruitingNCT05283109
What this trial is testing

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM

Who this might be right for
Glioma, Malignant
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 24
Testing effectiveness (Phase 2)Study completedNCT00004200
What this trial is testing

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Early research (Phase 1)Ended earlyNCT01558687
What this trial is testing

Cilengitide Imaging Trial in Glioblastoma

Who this might be right for
Supratentorial Newly Diagnosed Inoperable Gliobastoma
Merck KGaA, Darmstadt, Germany 1
Testing effectiveness (Phase 2)Study completedNCT01402063
What this trial is testing

PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation

Who this might be right for
Glioblastoma Multiforme
Brown University 63
Early research (Phase 1)Looking for participantsNCT07141732
What this trial is testing

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Who this might be right for
Glioblastoma
Joint Stock Company European Medical Centre 15
Large-scale testing (Phase 3)Looking for participantsNCT03970447
What this trial is testing

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Global Coalition for Adaptive Research 2,250
Testing effectiveness (Phase 2)Active Not RecruitingNCT03197506
What this trial is testing

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaSupratentorial Glioblastoma
Mayo Clinic 52
Very early researchStudy completedNCT01867593
What this trial is testing

MET-PET for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Massachusetts General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03522298
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Who this might be right for
Glioblastoma, Adult
Kazia Therapeutics Limited 30
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Very early researchActive Not RecruitingNCT03893487
What this trial is testing

Fimepinostat in Treating Brain Tumors in Children and Young Adults

Who this might be right for
Diffuse Intrinsic Pontine GliomaRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma+2 more
Sabine Mueller, MD, PhD 30
Not applicableStudy completedNCT00499798
What this trial is testing

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility
Wake Forest University Health Sciences 16
Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Not applicableStudy completedNCT06346821
What this trial is testing

Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data

Who this might be right for
Glioblastoma Multiforme
Sichuan University 181
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Testing effectiveness (Phase 2)Looking for participantsNCT06504381
What this trial is testing

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Who this might be right for
High Grade GliomaMGMT-Unmethylated GlioblastomaMGMT-Methylated Glioblastoma
University of California, San Francisco 70
Load More Results